PTGS2 and lung cancer: Cyclooxygenase 2 (COX-2) has been reported to be involved in inflammatory environments and lung cancer pathogenesis, and lipopolysaccharide treatment induced YY1 binding to the homologous site of endogenous COX-2 promoter YY1 and enhances its transcriptional activity in macrophages.